A few of our accomplishments over our 28 year plus history. • 1977: Meridian founded. • 1996, 1997, 2000, 2003, 2004 & 2005: Forbes “Best 200 Small Companies”. • 2001: Meridian Diagnostics becomes Meridian Bioscience, Inc. and expands into the life science industry. • 2004, 2005 & 2006: Meridian included in Mergent’s Dividend Achievers Index due to its long history of dividend increases. • 2004: Meridian achieves ISO 13485 Certification. • 2005: Meridian ranked 80th on Fortune Small Business - Fastest Growing Small Companies. • 01/19/06: Meridian Bioscience Reports Record First Quarter Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2006 Guidance • 02/24/06: Meridian Bioscience Named Founding Member to New NASDAQ Dividend Achievers Index • 05/03/06: Meridian Bioscience Added to Mergent's Dividend Achievers Index • 06/26/06: FORTUNE Small Business Ranks America's Fastest-Growing Small Companies • 07/06/06: Meridian Bioscience Announces Its Inclusion in the New NASDAQ Global Select Market - The Market With the Highest Initial Listing Standards in the World Meridian was first-to-market with several key products over our history: • Rapid C. difficile Antigen Test • C. difficile Toxin A Test • H. pylori Antigen Test • E. coli O157 Plus, Direct Stool Test • Rapid C. difficile Toxin A and B Test • Shiga Toxin Test Meridian is the market leader in parasitology transports and provides products for the clinical lab “Collection through Detection & Design”. Our broad product menu offers more than 200 products to meet our customers’ needs. Our Cincinnati global headquarters houses research and development, manufacturing, warehousing, and administrative offices. Meridian employs approximately 400 people worldwide.